Podcast


Presenter: Dr. James McCormack Dr. Mike Allan Dr. Nicholas Dugré

In episode 579, Mike and James invite Nicholas Dugré back to the podcast to talk about the evidence around the benefits and harms of a new class of medications for the acute treatment of episodic migraines. Ubrogepant is an oral calcitonin gene-related peptide antagonist. In this case, amazing as it may sound, there are triple…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Case 55: Fatigue, Part I

In this episode of In the Clinic, the team discusses Leah Sandwich, 64-year-old woman presenting with fatigue. To earn an additional 0.25 credits, please click the link below to complete…
Listen 0.5 credits available

In the Clinic Case 54: Anxiety

In this episode of In the Clinic, the team discusses Adrian Cage, a 42-year-old father of two presenting with anxiety. To earn an additional 0.25 credits, please click the link…
Listen 0.5 credits available

In the Clinic Episode 53: Palpitations

In this episode of In the Clinic, the team discusses Val Sternbach, a 65-year-old presenting with racing heart and trouble breathing. To earn an additional 0.25 credits, please click the…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Mike Allan Dr. Nicholas Dugré

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Mike Allan
  • Dr. Nicholas Dugré

Spearkers do not have any conflicts of interest to declare.